Clough Capital Partners’s Transmedics TMDX Stock Holding History

Clough Capital Partners’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,119	Closed	-$866K	–	125
2025 Q4	$866K	Buy	+7,119	New	+$893K	0.08%	102
2024 Q4	–	Sell	-8,705	Closed	-$1.37M	–	164
2024 Q3	$1.37M	Buy	+8,705	New	+$1.34M	0.14%	84
2024 Q1	–	Sell	-4,599	Closed	-$363K	–	184
2023 Q4	$363K	Buy	4,599 +286	+7%	+$17.3K	0.04%	160
2023 Q3	$236K	Buy	+4,313	New	+$310K	0.03%	177

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clough Capital Partners's TMDX Position: Q1 2026 in Review

Clough Capital Partners sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 7,119 shares — an estimated $866K sold.

Clough Capital Partners first reported a position in TMDX in Q3 2023 and held it in 4 quarters. The position peaked at $1.37M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Clough Capital Partners reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
Clough Capital Partners sold 7,119 Transmedics shares in Q1 2026, an estimated $866K.
Clough Capital Partners first reported a position in Transmedics in Q3 2023 and held it in 4 quarters.
Clough Capital Partners's Transmedics position peaked at $1.37M in Q3 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Clough Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.